Fundraising FoxLeaps by Bayer — 2023 Investments
6 investments dated 2023 · listed companies and verified rows first · show all
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesClavystBio
American Autonomy develops drone software solutions for agricultural equipment manufacturers, including ground control stations, data management systems, and ecosystem integrations to enable farmers to access and utilize drone-collected data for decision-making.
AgTechAI & Machine LearningEnterprise SoftwareHardwareRoboticsSaaSIowa City, US
Mariah Scott(CEO)in
Co-investorsAg Ventures AllianceAgLaunch AcceleratorFulcrum Global Capital
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsAccelr8Capria VenturesCavallo VenturesGermin8 VenturesKdT VenturesSunna Ventures+3 more
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in
Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+7 more
Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.
AI & Machine LearningBiotechDeep TechUnited States, US
Co-investorsARCH Venture PartnersClavystBioEcoR1 Capital
Iowa City, US
Matthew Beckwith(Executive Officer, Director)Michael Ott(Executive Officer, Director)
Co-investorsFulcrum Global CapitalInnova Memphis, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.